arrow
C

Catharine West

The University of Manchester
H指数:83
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study

基于EORTC QLQ-C30的五年内放疗后长期疲劳及其在REQUITE国际研究中确诊为非转移性前列腺癌男性的轨迹

2026-11-040
OAAI
A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer

血浆衍生的低氧特征预测低氧调节放射治疗的获益并揭示膀胱癌中动态体液免疫调节

2026-09-260
OAAI
Technical note: reconstructing dose distributions from manually planned electron boosts in breast radiotherapy

技术说明:乳腺癌放射治疗中手动计划电子束推量重建剂量分布

2026-08-010
OAAI
Hypoxia-associated gene signature for uterine cervical cancer

子宫颈癌缺氧相关基因特征

2026-08-010
PRE
Oxygen-enhanced MRI in patients with uterine cervical carcinoma: feasibility and treatment-associated changes in tumour oxygen-enhanced response

子宫颈癌患者的氧增强MRI:可行性及治疗相关的肿瘤氧增强反应变化

2026-07-260
OAAI
Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial

前列腺癌或肺癌患者身体成分与放疗相关副作用及健康相关生活质量的关系:REQUITE试验的亚组分析

2026-06-010
PRE
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients

前列腺癌患者放疗后2年内疲劳的遗传决定因素

2026-04-220
OAAI
Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicity

纵向血浆纳米蛋白质组学揭示了放射治疗引起的急性全身反应和晚期毒性的预测生物标志物

2026-04-010
OAAI
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Is it feasible to randomize between treatment with stereotactic body radiotherapy (SBRT) versus high dose rate brachytherapy (HDR BT)?

既往接受放疗的前列腺癌患者的再放疗方案(RO-PIP):能否随机比较立体定向体部放疗(SBRT)与高剂量率近距离放疗(HDR BT)的治疗?

2026-02-190
OAAI
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study

基因组风险模型在临床护理中实施精准前列腺癌筛查的进展研究

2026-01-260
PRE
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy

利用机器学习预测接受放射治疗的前列腺癌患者报告的症状群集

2025-11-290
OAAI
Intra-voxel incoherent motion biomarker repeatability in healthy volunteers and sensitivity to chemoradiotherapy-induced changes in patients with uterine cervical cancer

体素内不相干运动生物标志物在健康志愿者中的重复性及对子宫颈癌患者化疗放疗诱导变化的敏感性

2025-11-260
OAAI
Unveiling regions associated with acute and late breast side-effects from breast radiotherapy using voxel-wise image-based data mining analysis

通过体素级图像基于数据挖掘分析揭示与急性及晚期乳腺癌放疗相关的不良反应区域

2025-10-250
PRE
Primary results for the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010)

III期临床试验“使用质子束疗法减少口咽癌毒性的研究”(TORPEdO;CRUK/18/010)的初步结果

2025-10-140
PRE
Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy

膀胱在前列腺癌放射治疗中剂量-反应模型参数的敏感性分析

2025-10-090
OAAI
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer

辐射诱导的细胞外基质重塑驱动预后并预测肌肉浸润性膀胱癌的放射治疗反应

2025-07-290
OA
Combining MRI radiomics, hypoxia gene signature score and clinical variables for prediction of biochemical recurrence-free survival after radiotherapy in prostate cancer

结合MRI放射组学、缺氧基因特征评分和临床变量,预测前列腺癌放疗后的生化复发无进展生存期。

2025-07-020
OAAI
Dose-response mapping of bladder and rectum in prostate cancer patients undergoing radiotherapy with and without baseline toxicity correction

前列腺癌患者放疗中膀胱和直肠的剂量-反应关系映射(有无基线毒性校正)

2025-07-010
OAAI
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy

缺氧相关基因特征在接受雄激素剥夺治疗和放射治疗的高危局限性前列腺癌中不是预后的

2025-03-010
OAAI